跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
藥學系
臺北醫學大學
藥學院
電話
+886-2-27361661#6192 +886-2-27361661#6193
電子郵件
pharmacy@tmu.edu.tw
網站
http://pharmschool.tmu.edu.tw/
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(35)
專案
(399)
研究成果
(1546)
資料集
(83)
指紋
查看啟用 藥學系 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine & Life Sciences
Taiwan
100%
Histone Deacetylase Inhibitors
81%
Neoplasms
65%
Inhibitory Concentration 50
52%
Apoptosis
52%
In Vitro Techniques
52%
Histone Deacetylases
41%
Growth
41%
Proteins
40%
Population
40%
Pharmaceutical Preparations
39%
Cell Line
38%
Lipopolysaccharides
35%
Anti-Inflammatory Agents
35%
Pharmacokinetics
34%
Therapeutics
34%
High Pressure Liquid Chromatography
33%
Mucocutaneous Lymph Node Syndrome
32%
Cohort Studies
31%
Antineoplastic Agents
31%
Colorectal Neoplasms
30%
Cyclooxygenase 2
30%
Antioxidants
30%
Breast Neoplasms
27%
Genes
27%
Tubulin
26%
Acids
26%
isosteviol
25%
Tubulin Modulators
25%
Nitric Oxide
24%
Water
24%
Micelles
23%
Down-Regulation
23%
Non-Small Cell Lung Carcinoma
23%
Macrophages
22%
Gene Expression
22%
Phosphorylation
22%
Autophagy
22%
aristolochic acid I
21%
Cell Movement
21%
Rabbits
20%
Microtubules
20%
Ethanol
20%
Biological Availability
20%
Resveratrol
20%
Cell Proliferation
20%
osthol
20%
Pyruvaldehyde
20%
Pharmacists
20%
Inflammation
20%
Heterografts
20%
Nanoparticles
20%
Xanthine Oxidase
20%
Lung Neoplasms
20%
Colonic Neoplasms
19%
Nitric Oxide Synthase Type II
19%
Lignans
19%
Drug Delivery Systems
19%
indoline
18%
Lactic Acid
17%
Kidney
17%
Dinoprostone
17%
Single Nucleotide Polymorphism
17%
Interleukin-1
17%
3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
17%
Cell Death
17%
Databases
17%
Glycosides
17%
Serum
16%
Reactive Oxygen Species
16%
Mass Spectrometry
16%
Hydrolyzable Tannins
16%
Histone Deacetylase 6
16%
Acetylation
16%
Solubility
16%
Antrodia
16%
benzenesulfonamide
16%
Hepatocellular Carcinoma
16%
Vorinostat
15%
Chinese Traditional Medicine
15%
hispidulin
15%
Wounds and Injuries
15%
Tablets
15%
Messenger RNA
15%
Structure-Activity Relationship
15%
Neoplasm Metastasis
14%
Prostatic Neoplasms
14%
Confidence Intervals
14%
Calcium
14%
RAW 264.7 Cells
14%
A549 Cells
14%
Liver
14%
Drug Liberation
14%
Western Blotting
14%
Cantharidin
14%
Molecular Dynamics Simulation
14%
shikonin
14%
Hydroxamic Acids
14%
Caspase 3
14%
Matrix Metalloproteinases
14%
Chemical Compounds
Protein
59%
Drug
56%
Histone
53%
Antiproliferative
41%
Antiinflammatory
29%
Antioxidant Agent
29%
Antitumor
26%
Antineoplastic Agent
26%
Pharmacokinetics
25%
Plasma
24%
Nitric Oxide
24%
Metabolite
23%
Bioavailability
22%
Aristolochic Acid
20%
Apoptotic
19%
Percutaneous
19%
Dose
19%
High-Pressure Liquid Chromatography
18%
Acid
18%
Genetic Polymorphism
17%
Leaf Like Crystal
17%
Lipopolysaccharide
16%
Application
16%
Hydroxamic Acid
16%
Methylglyoxal
15%
Lignan
14%
Flavonoid
14%
50 Percent Growth Inhibition
14%
Cell Death
14%
Cantharidin
14%
Glycoside
14%
Nanoparticle
14%
Micelle
13%
Reactive Oxygen Metabolite
13%
Marker
13%
Bioactivity
13%
Amount
13%
Hydrolysable Tannin
12%
Quercetin
12%
Colchicine
12%
Modification
12%
Column Like Crystal
12%
Free Radical
12%
Resveratrol
12%
Ethanol
12%
Polymerization Reaction
12%
Collagen
12%
Structure-Activity Relationship
12%
Resistance
12%
Shikonin
12%
Composite Material
11%
Protective
11%
Solubility
11%
Disorder
11%
Oxidative Stress
11%
Dissolution
11%
3-Hydroxybutyrate
10%
Metabolic
10%
Tannin
10%
Alkannin
10%
Lipid
10%
Chitosan
10%
Glucose
10%
Microcrystallinity
10%
Prostaglandin E2
10%
Granulation
9%
Enantiomer
9%
Osthole
9%
Superoxide
9%
Vascular Targeting Agent
9%
Western Blotting
9%
Hydrogel
9%
Cell Viability
9%
Calcium(0)
9%
Time
9%
Succinate
9%
Retinal
9%
Sildenafil
9%
Prostaglandin E1
9%
Simulation
9%
Nifedipine
9%
Wogonin
8%
Weight
8%
Liquid Film
8%
Poly(ethylene Glycol)
8%
Acetylation
8%
Pharmacological Metabolism
8%
Liquid
8%
Liquid Chromatography
8%
Indoline
8%
Biological Marker
8%
Gel
8%
Hispidulin
8%
Antiapoptotic
8%
Fragmentation
8%
Diclofenac Sodium
8%
Flow
8%
Excipient
8%